About StackItSmart
StackItSmart is an independent, evidence-based harm-reduction reference for people who use performance-enhancing compounds. It exists because reliable pharmacokinetic data for these substances is scattered across academic journals and buried in clinical trial archives — and because forum advice has real clinical consequences.
What this site is
A consolidated, citation-first reference for steroids, SARMs, peptides, ancillaries, and post-cycle therapy. Every compound page has a half-life drawn from the literature, a dosing range sourced to a paper or explicitly marked as community-reported, and a PCT timing recommendation derived from apparent depot half-life rather than folklore.
The cycle builder uses the same data: it scores suppression against graduated thresholds, enforces a no-dual-17α-alkylated rule, and routes PCT through a single-SERM-only generator. Nothing here is AI-dreamed; math and peer-reviewed values produce the output.
What this site is not
- Not medical advice, not an endorsement, not a recommendation to use any compound.
- Not a sourcing guide. StackItSmart does not link to or discuss procurement of controlled substances.
- Not reviewed by a licensed clinician — yet. Clinical sign-off is a tracked milestone; until it lands, every compound page carries this caveat inline.
- Not AI-generated content. Data is compiled from published PK studies and clinical trials, with each claim traceable to a source.
Who built it
Eli Gorelick — founder and developer. Independent software engineer. Not a medical professional. My role is engineering: schema design, clinical-data validation, and shipping a product that makes peer-reviewed pharmacology as easy to look up as a forum post.
All factual content is compiled from cited peer-reviewed literature. Where community usage diverges from clinical evidence, the content marks it explicitly. Where a claim is unsupported, it's flagged rather than smoothed over.
- eligorelick.com — portfolio
- github.com/eligorelick — open-source work
Editorial policy
- Never recommend dual-SERM PCT — extend a single SERM instead.
- Never provide sourcing guidance for controlled substances.
- Every compound page carries a “not medical advice” disclaimer inline.
- 21+ hard age-gate on cycle generation; under-25 warning.
- Oral 17α-alkylated compounds capped at 6 weeks; no dual-17αα stacking.
- Clinical claims are cited; unsupported claims are flagged as community-reported, not smoothed over.
Data licensing
The compound reference corpus, interaction matrix, and bloodwork reference ranges are published under the Creative Commons Attribution 4.0 license. Suggested citation:
StackItSmart. Evidence-Based Harm Reduction Reference (2026). https://stackitsmart.com